Hims & Hers shares technical analysis: Range-bound trading persists above $26.38 support

Traders Union
All News
Stocks
Hims & Hers slides 0.4% today

Highlights

Hims & Hers Health faces legal and reputational risk after a securities class action tied to FTC allegations of improper data sharing and billing practices.
Regulatory scrutiny has increased uncertainty over outcomes for the company, introducing additional overhang and weakening stock performance.
Shares trade below short- and medium-term moving averages with bearish momentum signals, with the next expected range at $26.38 to $28.8.

Legal uncertainty rises as regulatory complaint dampens sentiment

Hims & Hers Health, Inc. has come under regulatory scrutiny following a securities class action lawsuit initiated by a July 29, 2026 Federal Trade Commission complaint alleging consumer health information was shared with third-party advertisers, along with problematic billing and subscription practices, according to PR Newswire. This introduces significant legal and reputational risk for the company, increasing regulatory overhang and dampening investor sentiment. Resulting uncertainty around potential outcomes may have contributed to pressure on the share price.

Prevailing sell signals as price tests downside boundaries

Technically, HIMS trades below the MA-20 and MA-50 on the hourly chart while remaining above the MA-200, highlighting immediate downside risk but longer-term trend support. The Ichimoku Kijun at $28.49 marks the closest resistance to the upside. Momentum signals are negative, with both MACD and ADX showing prevailing sell pressure, while RSI and CCI indicate ongoing weakness without signs of exhaustion. Stoch RSI is neutral, and the Bull/Bear Power suggests sellers dominate short-term momentum. The Awesome Oscillator is neutral, providing no clear directional bias.

Downside favored as consolidation stalls potential rebound

In the short term, HIMS is expected to consolidate within a typical volatility band of $26.38 to $28.8. The probability of upward movement is very low, with a high likelihood of further downside. A close above resistance at $28.49 could signal a shift toward higher levels, while a breakdown below $26.38 would suggest the risk of deeper declines.

Anton Kharitonov, analyst at Traders Union, sees Hims & Hers under heavy pressure from regulatory risk and market sentiment following the FTC complaint and lawsuit. He notes that price struggles below key moving averages and momentum remains negative, hinting at further downside until uncertainty clears. Support near $26.38 could be retested if sellers persist. "Given unresolved legal issues and technical weakness, I remain cautious and would avoid fresh longs until we see evidence of renewed buyer interest above $28.49."

Earlier, analysts noted that Hims & Hers Health faced persistent short- and medium-term downside pressure driven by legal and regulatory risks. The current analysis reinforces this perspective, with heightened regulatory scrutiny and negative momentum suggesting traders should monitor the $28.49 resistance and $26.38 support as pivotal levels for potential trend shifts.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.